Last reviewed · How we verify
NCT06053593
Ketostix® and Keto-Diastix® Performance Study
trial testing Testing of self collected urine in Urinalysis in 126 participants. Completed in 30 November 2023.
30 November 2023
Quick facts
| Lead sponsor | Ascensia Diabetes Care |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 126 |
| Start date | 24 July 2023 |
| Primary completion | 30 November 2023 |
| Estimated completion | 30 November 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Testing of self collected urine
- Labeling Evaluation
- Urine Control testing
Conditions studied
- Urinalysis — all drugs for Urinalysis →
Sponsor
Ascensia Diabetes Care
Who can join
18 and older, any sex, with Urinalysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Persons with Diabetes (PWDs), at minimum of (n=120) will successfully collect their urine and test with two Ascensia strip products. The products are: Ketostix and Keto-Diastix.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06053593
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ascensia Diabetes Care trials
Trials by the same sponsor.
- NCT05449795 — Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults · completed
- NCT05467345 — Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples · completed
- NCT05647824 — User Performance of the TV4 BGMS · completed
- NCT04033315 — Performance of the L-PLUS BGMS by Persons With Diabetes Mellitus · completed
- NCT04008836 — User Performance of the Thunder Plus BGMS · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06053593 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ascensia Diabetes Care
- Last refreshed: 29 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06053593.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing